2021-03-07

U.S. Senate passes economic stimulus plan, fourth vaccine is expected to be approved in the U.S.

By yqqlm yqqlm

China News Service, March 7th. According to a comprehensive report, on the 6th local time, the US Senate passed a $1.9 trillion economic stimulus plan to deal with the impact of the new crown epidemic on the economy. The United States is accelerating its vaccination plan, and the British company AstraZeneca said it plans to apply for emergency use authorization for its vaccine in the United States in the next few weeks.

The U.S. Senate approved the US$1.9 trillion economic stimulus plan

On the 6th local time, the US Senate passed 50 votes in favor and 49 votes against it, and voted to pass the US$1.9 trillion economic stimulus. plan.

U.S. Senate passes economic stimulus plan, fourth vaccine is expected to be approved in the U.S.

The plan passed this time includes granting US$1,400 per person to eligible Americans; providing US$300 in weekly unemployment benefits; injecting US$14 billion into the new crown vaccination program; providing US$130 billion for the reopening of schools; Enterprises affected by the epidemic provided 25 billion U.S. dollars in assistance.

U.S. President Biden said in a speech on the Senate’s economic stimulus plan, “This (process) is obviously not easy, it is not always good, but Americans urgently need (this plan).”

Because the plan passed by the Senate is slightly different from the previous version approved by the House of Representatives, it must now be sent back to the House of Representatives for trial.

The majority leader of the House of Representatives, Hoyer, stated on social networking sites that the House of Representatives will vote on the version approved by the Senate on the 9th. After the House of Representatives vote is passed, it will be submitted to Biden for signature, and Biden is expected to sign it into law before March 14.

The fourth vaccine in the United States is expected to be launched

The cumulative number of confirmed cases in the United States exceeds 28.94 million, and the number of deaths exceeds 524,000. At present, the US epidemic data is slowing down, and there are increasing calls from various regions to restart commercial activities and resume classes in schools.

U.S. Senate passes economic stimulus plan, fourth vaccine is expected to be approved in the U.S.(1)

<

p > New York City recently allowed restaurants to resume indoor dining on a limited basis; California announced on the 5th that Disneyland and other theme parks, which had been closed for nearly a year due to the epidemic, were allowed to reopen on April 1.

However, the US Centers for Disease Control and Prevention issued a report on the 5th, pointing out that the data showed that after 41 days or about six weeks after the restaurant was allowed to resume dine-in (indoor or outdoor dining), the number of new cases per day in the county and city It began to increase, and the number of deaths showed an upward trend two months later; 20 days after the mandatory wearing of masks was promulgated, the number of newly diagnosed and death cases per day decreased significantly.

The United States is currently accelerating its new crown vaccination plan. An executive of the British pharmaceutical company AstraZeneca revealed on the 5th that the company plans to apply for emergency use authorization for its vaccine in the United States in the next few weeks.

Ruud Dobber, executive vice president of AstraZeneca, said that the company hopes to receive the results of clinical trials in the United States in the “coming weeks”, and then plans to immediately report to the U.S. Food and Drug Administration. The bureau seeks emergency use authorization for the vaccine. He said that if authorized, AstraZeneca is ready to provide tens of millions of doses of vaccine to the United States.